Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. DEF 14A Proxy Proxy Statement
  4. DEF 14A Proxy Proxy Statement
  5. DEF 14A Proxy Proxy Statement
  6. DEF 14A Proxy Proxy Statement
  7. DEF 14A Proxy Proxy Statement
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement
  11. DEF 14A Proxy Proxy Statement
  12. DEF 14A Proxy Proxy Statement
  13. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 13 filings